Biological patent and patentability

Raman Singh, Kuldeep Singh

Abstract


Development in the field of Biological patent sprouted a new world in biotechnology, which permits scientist to alter natural biological matter for commercial profit. In response to Scientific Breakthrough in biotechnology, the innovative technologies, demand of capitalist market place and patent law has expanded to accommodate a range of biological inventions. There is always a controversial concept and views whether gene patenting have a positive impact upon research and development, health care and the protection of the environment or not. So, the applicability of patent of substance and process of   natural origin is always a topic of discussion or debate which may have either of the faces. The scope and reach of biological patents vary among Jurisdictions. Beside all this, this article provides some glimpses of basic Knowledge of   biological patents with their need, types and few landmark examples.

Keywords


Biological Patent, Need, Development, Scope, types patentability

Full Text:

PDF

References


F. Darwin. Francis Galton. Eugen. Rev. 1914, 6 (1), 1–17.

J.P. Horwitz, J. Chua, M. Noel. Nucleosides. V. The Monomesylates of 1-(2’-Deoxy-β-D-lyxofuranosyl)thymine 1,2. J. Org. Chem. 1964, 29 (7), 2076–2078.

S. Borman. Burroughs Wellcome’s AZT patents upheld. Chem. Eng. News 1994, 72 (49), 8.

H. Newiss. The patenting of genetically modified foods. Trends Food Sci. Technol. 1998, 9 (10), 368–371.

H.S. Chawla. Patenting of Biological Material and Biotechnology. J. Intellect. Prop. Rights 2005, 10, 44–51.

Z. Lei, R. Juneja, B.D. Wright. Patents versus patenting: implications of intellectual property protection for biological research. Nat. Biotechnol. 2009, 27 (1), 36–40.

M. Newhouse, B. Tagg, S.J. Pocock, A.C. Mcewan. AN EPIDEMIOLOGICAL STUDY OF WORKERS PRODUCING ENZYME WASHING POWDERS. Lancet 1970, 295 (7649), 689–693.

S. Brooks. Biotechnology and the Politics of Truth: From the Green Revolution to an Evergreen Revolution. Sociol. Ruralis 2005, 45 (4), 360–379.

Y. Xiang, Y. Lu. Using personal glucose meters and functional DNA sensors to quantify a variety of analytical targets. Nat. Chem. 2011, 3 (9), 697–703.

R.G. Clark, H.B. Robinson, I.C.A.F. Lowman. Insulin-like growth factor agonist molecules. 6,251,865, 2001.

M. Sterpi, T.J. Calame. Patent Litigation: Jurisdictional Comparisons; The European lawyer reference; Sweet & Maxwell, Thomson Reuters, 2011.

D.B. Resnik. Owning the Genome: A Moral Analysis of DNA Patenting; Book collections on Project MUSE; State University of New York Press, 2012.

M.D. Pozo. Patenting Genes: The Requirement of Industrial Application; Edward Elgar, 2017.

G. Carey. Human Genetics for the Social Sciences; Advanced Psychology Text Series; SAGE Publications, 2003.

K.F. Greif, J.F. Merz, A.L. Caplan. Current Controversies in the Biological Sciences: Case Studies of Policy Challenges from New Technologies; Basic Bioethics; MIT Press, 2007.

A.L.R. Commission. Genes and ingenuity: report : gene patenting and human health; Report (Australia. Law Reform Commission); Australian Law Reform Commission, 2004.

C. Roy. The Role of Intellectual Property Rights in Agriculture and Allied Sciences; Apple Academic Press, 2018.

W.I.P. Organization. Budapest Treaty on the International Recognition of the Deposit of Microorganisms for the Purposes of Patent Procedure: Done at Budapest on April 28, 1977, and Amended on September 26, 1980 and Regulations; WIPO publication; World Intellectual Property Organization, 1997.

W.I.P. Organization. Guide to the Deposit of Microorganisms Under the Budapest Treaty; World Intellectual Property Organization, 2010.

Section 3a-3p, 4, 5 of Indian Patent Act1970& amendments 1999, 2002, 2005.

Judgment of the Hon'ble High Court of Calcutta dated 15.01.2002 IPLR 2002 July. 255 Dimminaco A.G. v. Controller of Patents


Refbacks

  • There are currently no refbacks.




ISSN 2348 –0874